This compound is primarily utilized in the field of medicinal chemistry and drug development, particularly in the design and synthesis of targeted therapies. It serves as a key intermediate in the production of prostate-specific membrane antigen (PSMA) inhibitors, which are crucial for developing treatments for prostate cancer. The compound’s structure allows it to bind specifically to PSMA, enabling the delivery of therapeutic agents directly to cancer cells, thereby minimizing damage to healthy tissues. Additionally, it is employed in the preparation of radiopharmaceuticals for diagnostic imaging, aiding in the precise detection and localization of prostate cancer tumors. Its role in enhancing the efficacy and specificity of cancer treatments makes it a valuable component in advanced oncology research.